Dexcom, Inc. FDA Record
- Latest inspection NAI · Nov 7, 2024
- 16 Class I recalls
- Last warning letter 2025
Dexcom, Inc. has 29 FDA recalls (16 Class I), 12 inspections, 28 510(k) clearances and 3 compliance actions on record. FDA has issued 3 warning letters to Dexcom, Inc., the most recent on Mar 4, 2025.
- Latest recall
- Z-2574-2026 · Class II · May 27, 2026
- Latest inspection
- Nov 7, 2024 · NAI
- Latest 510(k)
- Aug 11, 2026
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 29 (16 Class I) | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 28 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 12 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 3 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
FDA record by year
Dexcom, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 4 | 0 |
| 2025 | 0 | 0 | 1 | 14 | 10 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 1 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 1 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 3 | 0 |
| 2019 | 0 | 0 | 0 | 2 | 0 |
| 2018 | 2 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Dexcom, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Dexcom, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Dexcom, Inc. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Mar 4, 2025 · Letter on fda.gov | CGMP/QSR/Medical Devices/Adulterated | Center for Devices and Radiological Health | |
| Mar 14, 2014 · Record page | |||
| May 21, 2010 · Record page |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| Z-2574-2026 | Class II | Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 US Retail… | May 27, 2026 |
| Z-2163-2026 | Class II | Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM iOS App… | Apr 14, 2026 |
| Z-2165-2026 | Class II | Brand Name: Dexcom ONE+ Continuous Glucose Monitoring System Product Name: Dexcom ONE+ iOS CGM App… | Apr 14, 2026 |
| Z-2164-2026 | Class II | Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM watchOS App… | Apr 14, 2026 |
| Z-0318-2026 | Class I | Brand Name: Dexcom G6 Continuous Glucose Monitoring System Product Name: Dexcom G6 and G6 Pro… | Aug 28, 2025 |
| Z-2448-2025 | Class I | Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM watchOS App… | Jul 24, 2025 |
| Z-2446-2025 | Class I | Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM Android App… | Jul 24, 2025 |
| Z-2447-2025 | Class I | Brand Name: Dexcom G7 Continuous Glucose Monitoring System Product Name: Dexcom G7 CGM iOS App… | Jul 24, 2025 |
| Z-2449-2025 | Class I | Brand Name: Dexcom ONE+ Continuous Glucose Monitoring System Product Name: Dexcom ONE+ Android CGM… | Jul 24, 2025 |
| Z-2450-2025 | Class I | Brand Name: Dexcom ONE+ Continuous Glucose Monitoring System Product Name: Dexcom ONE+ iOS CGM App… | Jul 24, 2025 |
| Z-1943-2025 | Class I | Dexcom G6 Glucose Receiver, SKUs (Part Number): STK-FM-001 (MT27408-1) & STK-FR-001 (MT27408-1) | May 12, 2025 |
| Z-1946-2025 | Class I | Dexcom One Continuous Glucose Monitoring System, SKUs(Part Number): STK-DO-006 (MT27409-1)… | May 12, 2025 |
| Z-1944-2025 | Class I | Dexcom G7 Glucose Receiver, SKUs (part number): STK-AT-011(MT26403-0), STK-AT-012 (MT26403-0)… | May 12, 2025 |
| Z-1945-2025 | Class I | Dexcom One+ Continuous Glucose Monitoring System, SKU(Part Number): STK-D7-013 (MT28285-1)… | May 12, 2025 |
| Z-1906-2025 | Class II | Dexcom G7 iOS Application, Ref: SW12300 used in conjunction with the Dexcom G7 Continuous Glucose… | May 5, 2025 |
| Z-1203-2025 | Class II | Dexcom G6, Continuous Glucose Monitoring System, REF: STK-OR-001 | Jan 27, 2025 |
| Z-1202-2025 | Class II | Dexcom G6, Continuous Glucose Monitoring System, REFs: STK-OM-001, STR-OM-001, STR-OR-001 | Jan 27, 2025 |
| Z-1204-2025 | Class II | Dexcom G6, Continuous Glucose Monitoring System, REF: STK-OE-001 | Jan 27, 2025 |
| Z-1561-2020 | Class II | Dexcom G5 Continuous Glucose Monitoring System The Dexcom G4 PLATINUM Continuous Glucose… | Feb 3, 2020 |
| Z-1560-2020 | Class II | Dexcom G4 PLATINUM Continuous Glucose Monitoring System The Dexcom G4 PLATINUM Continuous Glucose… | Feb 3, 2020 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Nov 7, 2024 | San Diego, CA | Devices | No Action Indicated (NAI) | 3004753838 |
| Sep 29, 2023 | San Diego, CA | Devices | No Action Indicated (NAI) | 3004753838 |
| Sep 17, 2021 | San Diego, CA | Devices | Voluntary Action Indicated (VAI) | 3004753838 |
| Mar 22, 2018 | Mesa, AZ | Devices | No Action Indicated (NAI) | 3013435121 |
| Feb 16, 2018 | San Diego, CA | Devices | Voluntary Action Indicated (VAI) | 3004753838 |
| Mar 29, 2016 | San Diego, CA | Devices | Voluntary Action Indicated (VAI) | 3004753838 |
| Apr 21, 2015 | San Diego, CA | Devices | No Action Indicated (NAI) | 3004753838 |
| Nov 7, 2013 | San Diego, CA | Devices | Official Action Indicated (OAI) | 3004753838 |
| Jul 18, 2012 | San Diego, CA | Devices | No Action Indicated (NAI) | 3004753838 |
| Oct 6, 2010 | San Diego, CA | Devices | No Action Indicated (NAI) | 3004753838 |
| Feb 8, 2010 | San Diego, CA | Devices | Official Action Indicated (OAI) | 3004753838 |
| Dec 10, 2008 | San Diego, CA | Devices | No Action Indicated (NAI) | 3004753838 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 3 compliance actions under Dexcom, Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3004753838 | San Diego, CA | 11 | Nov 7, 2024 |
| FEI 3013435121 | Mesa, AZ | 1 | Mar 22, 2018 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K262472 | Stelo Glucose Biosensor System | Aug 11, 2026 |
| K260935 | Stelo Glucose Biosensor System | Jun 12, 2026 |
| K261402 | Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System | Jun 8, 2026 |
| K261359 | Stelo Glucose Biosensor System | May 21, 2026 |
| K253737 | Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring… | Feb 3, 2026 |
| K253710 | Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring… | Dec 17, 2025 |
| K252818 | Dexcom Smart Basal | Nov 18, 2025 |
| K243214 | Dexcom G7 15 Day Continuous Glucose Monitoring System | Apr 9, 2025 |
| K240902 | Dexcom G7 Continuous Glucose Monitoring System | Apr 23, 2024 |
| K234070 | Stelo Glucose Biosensor System | Mar 5, 2024 |
| K234133 | Dexcom G7 Continuous Glucose Monitoring System | Feb 26, 2024 |
| K231081 | Dexcom G7 Continuous Glucose Monitoring (CGM) System | May 15, 2023 |
| K223931 | Dexcom G6 Continuous Glucose Monitoring (CGM) System | Jan 11, 2023 |
| K213919 | Dexcom G7 Continuous Glucose Monitoring System | Dec 7, 2022 |
| K221259 | Dexcom G6 Continuous Glucose Monitoring (CGM) System, Dexcom G6 Glucose Program Continuous Glucose… | Jul 29, 2022 |
| K203089 | Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System | Aug 17, 2021 |
| K201328 | Dexcom G6 Continuous Glucose Monitoring (CGM) System | Jul 15, 2021 |
| K200876 | Dexcom G6 Continuous Glucose Monitoring System, Dexcom G6 Glucose Program Continuous Glucose… | Dec 4, 2020 |
| K193642 | Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System | Jan 29, 2020 |
| K192787 | Dexcom G6 Glucose Program Continuous Glucose Monitoring (GCM) System | Oct 25, 2019 |
Dexcom, Inc. and the FDA: common questions
Has Dexcom, Inc. received an FDA warning letter?
Yes. FDA has issued 3 warning letters to Dexcom, Inc.. The most recent is dated Mar 4, 2025, with the subject "CGMP/QSR/Medical Devices/Adulterated".
Has Dexcom, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Dexcom, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Dexcom, Inc.?
The most recent FDA inspection on file ended Nov 7, 2024 at San Diego, CA and was classified NAI. FDA has 12 inspections of Dexcom, Inc. on file, 2 of them classified OAI (official action indicated).
Has Dexcom, Inc. had an FDA recall?
Yes. Dexcom, Inc. has 29 FDA recalls on record, 16 of them Class I, the most serious class. The most recent started May 27, 2026.
Need more than this page shows? Ask about Dexcom, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.